Topicality of the problem of combined course of multi-drug resistant pulmonary tuberculosis with diabetes mellitus
DOI:
https://doi.org/10.14739/2310-1237.2017.2.109676Keywords:
multidrug-resistant tuberculosis, pulmonary tuberculosis, diabetes mellitusAbstract
According to the World Health Organization, today in the world among the infectious chronic diseases one of the leading places and causes of death is multi-drug resistant tuberculosis of the lungs, and chronic non-communicable diseases – diabetes mellitus. The situation is complicated by the fact that the number of patients with combined course of these two heavy separate illnesses that complicate each other increases. It is established that with increasing severity of diabetes mellitus, tuberculosis process in the lungs becomes more complicate and deteriorates, and vice versa, the specific process complicates the course of diabetes mellitus, contributing to the development of diabetic complications. Against this background, the effectiveness of treatment of patients suffering from multi-drug resistant tuberculosis of the lungs in our country remains very low, mainly due to the toxic adverse reactions to antimycobacterial drugs of the reserve line, and in the case of adding diabetes mellitus, it deteriorates even more.
The aim of this study was to review the scientific literature to determine the relevance of the study of combined course of multi-drug resistant tuberculosis of the lungs with diabetes mellitus and perspectives of innovative methods of diagnosis of diabetes mellitus. Early diagnosis of pre-diabetes, and autoimmune diseases will allow the use of timely correction techniques that prevents the development of diabetes mellitus, depending on its type, and in the future the development of serious irreversible processes, allow timely applying appropriate methods of correction of the revealed violations.
Results. Very little amount of work is dedicated to the problem of combined course of multi-drug resistant tuberculosis of the lungs with diabetes mellitus, regardless of its type, the theme is relevant for today, in Ukraine there are no data regarding its study. This combined course of very difficult in the treatment diseases requires not only timely and early diagnosis of autoimmune diseases associated with diabetes mellitus type 1 and pre-diabetes, but also additional complex combined therapy.
References
Shalmin, A. S., Raznatovskaya, E. N., Bobrovnichaya-Dvizova, Yu. M., Dvizov, A. V., Mulyar, N. V., & Fedchenko, T. S. (2012). Osobennosti sochetannogo techeniya tuberkuleza legkikh i sakharnogo diabeta [Features of the combined fl ow of pulmonary tuberculosis and diabetes mellitus]. Pathologia, 1(24). 92–94. [in Russian].
Komissarova, O. G. (2012). Tuberkulez u bol'nykh sakharnym diabetom. [Tuberculosis in patients with diabetes mellitus]. Tuberkulez i bolezni legkikh, 11, 3–7. [in Russian].
Papenova, E. L., Odinec, V. S., Zadremajlova, T. A., Vasilenko, T. I., & Akinina, S. A. (2015). Vliyanie rannego vyyavleniya tuberkuleza organov dykhaniya u bol'nykh sakharnym diabetom na e´ffektivnost' lecheniya v Stavropol'skom krae [Influence of Early Detection of Respiratory Tuberculosis in Patients with Diabetes Mellitus on the Effectiveness of Treatment in the Stavropol Territory]. Tuberkulez i bolezni legkikh, 7, 109–110. [in Russian].
Ministerstvo okhorony zdorov’ia Ukrainy (2012). Unifikovanyi klinichnyi protokol pervynnoi ta vtorynnoi (spetsializovanoi) medychnoi dopomohy. Tsukrovyi diabet 2 typu [Unified clinical protocol of primary and secondary (specialized) medical care. Type 2 diabetes mellitus]. Kyiv [in Ukrainian].
Dedov, I. I. (2012). Sakharnyj diabet – opasnejshij vyzov mirovomu sosobshhestvu. [Diabetes mellitus — a dangerous treat to the mankind]. Vestnik Rossijskoj akademii medicinskih nauk, 67(1), 7–13. [in Russian]. doi :10.15690/vramn.v67i1.103.
Sirenko, I. A., Levchenko, E. A., Sukhanova, L. A., & Marchenko, O. Yu. (2016). Problema tuberkuleza i saKharnogo diabeta [Tuberculosis and diabetes problem]. Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, 4(27), 54–59. [in Ukrainian].
Komissarova, O. G., Kossij, Yu. E., Abdullaev, R. Yu., Moiseeva, S. V., & Vasilyeva, I. A. (2013). Osobennosti techeniya i e´ffektivnost' lecheniya tuberkuleza legkikh s mnozhestvennoj lekarstvennoj ustojchivost'yu vozbuditelya u bol'nykh s raznymi tipami sakharnogo diabeta [Features of the course and efficacy of treatment of pulmonary tuberculosis with multiple drug-resistant pathogens in patients with different types of diabetes mellitus]. Tuberkuljoz i bolezni legkikh, 90(3), 010–014. [in Russian].
Komissarova, O. G., Konyayeva, O. O., Berezhnaya, O. O., Abdullayev, R. Yu., & Vasilyeva, I. A. (2015). E´ffektivnost' lecheniya bol'nykh tuberkulezom legkikh s mnozhestvennoj i shirokoj lekarstvennoj ustojchivost'yu vozbuditelya v sochetanii s raznymi tipami sakharnogo diabeta [Efficacy of Treatment of Patients with Multiple and Extensively Drug-Resistant Pulmonary Tuberculosis Combined with Different Types of Diabetes Mellitus]. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta, 3, 33–37. [in Russian].
Titov, V. N., & Shiryaeva, Yu. K. (2011). Glyukoza, glikotoksiny i produkty glikirovaniya, uchastie v patogeneze mikroangiopatiej, arterioloskleroza i ateroskleroza [Gyukose, glycotoxins and glycation products, participation in pathogenesis by microangiopathy, arteriolosclerosis and atherosclerosis]. Klinicheskaya laboratornaya diagnostika, 11, 3–13. [in Russian].
Kaminskaya, G. O., & Abdullaev, R. Y. (2014). Patofiziologicheskie predposylki neblagopriyatnogo vliyaniya sakharnogo diabeta na techenie tuberkuleza legkikh. [Pathophysiological prerequisites for the negative impact of diabetes mellitus on the course of pulmonary tuberculosis]. Tuberkuljoz i bolezni legkikh, 9(3), 5–11. [in Russian]. doi: http://dx.doi.org/10.21292/2075-1230-2014-0-3-5-11.
Kaminskii, A. V. (2012). Sakharnyj diabet. Chast' 1. Neprostye voprosy diagnostiki. [Sugar dyabet Part 1. Neprostыe Questions diagnosis]. Mezhdunarodnyj e´ndokrinologicheskij zhurnal, 3(43), 43–47. [in Russian].
Glinkina, I. V. (2012). Svoevremennoe nachalo insulinoterapii pri sakharnom diabete tipa 2: patogeneticheskoe i klinicheskoe obosnovanie [Timely initiation of insulin therapy for type 2 diabetes mellitus: pathogenetic and clinical justification]. Consilium medicum, 14(12), 10–15. [in Russian].
Smurova, T. V., & Kovaleva, S. I. (2007). Tuberkulez i sakharnyj diabet. [Tuberculosis and diabetes mellitus]. Moscow: Medkniga. [in Russian].
Baiburina, G. G. (2011). Immunologicheskie markery sakharnogo diabeta pri razlichnykh klinicheskikh tipakh zabolevaniya [Immunological markers of diabetes mellitus in various clinical variants of the disorder]. Medicinskaya immunologiya, 13(6), 623–626. [in Russian]. doi: http://dx.doi.org/10.15789/1563-0625-2011-6-623-626.
Dedov, I. I., Balabolkin, M. I., Klebanova, E. M., Kreminskaya, V. M., & Chazova, T. E. (2003). Sakharnyj diabet: patogenez, klassifikaciya, diagnostika i lechenie [Diabetes mellitus: pathogenesis, classification, diagnosis and treatment]. Moscow. [in Russian].
Titovich, E. V., Kuraeva,T. L., Prokofiev, S. A., Peterkova, V. A., & Dedov, I. I. (2010). HLA-galotipy, autoantitela k β-kletkam: rol' v prognozirovanii sakharnogo diabeta 1 tipa (rezul'taty 11-letnego nablyudeniya) [HLA-haplotypes, anti-β cell antibodies:their role in prognostication oftype 1 diabetes mellitus (results of 11-year observation)]. Sakharnyj diabet, 13(4), 12–17. [in Russian]. doi: http://dx.doi.org/10.14341/2072-0351-6051.
Larina, A. A., & Troshina, E. A. (2013). Autoimmunnye zabolevaniya, associirovannye s sakharnym diabetom 1-go tipa: vozmozhnoe vzaimovliyanie [Autoimmune diseases associated with type 1 diabetes mellitus: possible interplay]. Problemy e´ndokrinologii, 59(1), 35–43. [in Russian].
Derevyanko, O. S., Dalantaeva, N. S., Ivanova, O. N., Goncharov, N. P., Nikonova, T. V., & Smirnova, O. M. (2014). Markery autoimmunnogo porazheniya pecheni u pacientov s sakharnym diabetom 1 tipa [Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus]. Sakharnyj diabet, 1, 29–33. [in Russian]. doi: 10.14341/DM2014129-33.
Fadeyev, V., Abramova, N., Gitel, E., Pauncovic, N., Pauncovic, J., Prokofyev, S., & Melnichenko, G. (2006). Diagnosticheskoe znachenie opredeleniya urovnya antitel k receptoru tireotropnogo gormona metodami 1-go i 2-go pokolenij [Diagnostic Value of the First and Second Generation of Thyrotropin Receptor Antibodies in Clinical Practice]. Klinicheskaya i e´ksperimental'naya tireoidologiya, 2(2), 48–55. [in Russian].
Matveyeva, S. L. (2017). Vliyanie strukturno-funkcional'nykh izmenenij shhitovidnoj zhelezy na klinicheskoe techenie tuberkuleza i iskhody khimioterapii pri soputstvuyushhem sakharnom diabete [The effect of structural and functional changes in the thyroid gland on the clinical course of tuberculosis and the outcome of chemotherapy with concomitant diabetes mellitus]. Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, 1(28), 54–59. [in Russian].
WHO. (2015). Global Tuberculosis Report 2015 Retrieved from http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf.
World Health Organization. (2011). Use of glycated hemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. World Health Organization (WHO/NMH/ CHP/CPM/11.1).
World Health Organization. (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Department of Noncommunicable Disease Surveillance, Geneva.
Van den Driessche, A., Eenkhoorn, V., Gaal, L., & Block, C. (2009). Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Netherlands J Med, 67(11), 376–387.
Prázný, M., Skrha, J., Límanová, Z., Vanícková, Z., Hilgertová, J., Prázná, J., et al. (2005). Screening for Associated Autoimmunity in Type 1 Diabetes Mellitus With Respect To Diabetes Control. Physiol Res, 54, 41–48.
Vondra, K., Vrbikova, J., & Dvorakova, K. (2005). Thyroid gland diseases in adult patients with diabetes mellitus. Minerva Endocrinol, 30(4), 217–236.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
